NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-146-1999-0-US-01 Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point US 60/249,805 Abandoned
NCI E-127-2000-0-US-01 Camptothecin Compounds With a Sulfhydryl Group US ORD 09/712,912 6825206 Expired PDF
NIEHS E-270-1999-0-US-01 Methods For The Identification of Textual and Physical Structured Query Fragments For The Analysis of Textual and Biopolymer Information US 60/248,541 Abandoned
NICHD E-113-1999-0-US-01 Sol Fusin: Use of GP64-6HIS To Catalyze Membrane Fusion US 60/249,415 Abandoned
NIAID E-275-2000-1-US-01 Modifications of HIV ENV, GAG, and POL Enhance Immunogenicity For Genetic Immunization US 60/252,115 Abandoned
NCI E-317-1984-11-US-05 Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene US DIV 09/709,316 6706268 Expired PDF
NCI E-017-2000-0-PCT-02 Compositions and Methods for the Diminution or Elimination of Various Cancers PCT PCT PCT/US00/30869 Abandoned
NIAID E-263-1999-0-CA-13 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit CA National Stage 2391415 Abandoned
NIAID E-263-1999-0-EP-04 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit EP National Stage 00978467.9 Abandoned
NIAID E-263-1999-0-CH-11 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit CH EP 00978467.9 Abandoned
NIAID E-263-1999-0-DE-09 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit DE EP 00978467.9 Abandoned
NIAID E-263-1999-0-FR-08 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit FR EP 00978467.9 Abandoned
NIAID E-263-1999-0-AT-06 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit AT EP 00978467.9 Abandoned
NIAID E-263-1999-0-BE-07 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit BE EP 00978467.9 Abandoned
NIAID E-263-1999-0-IE-10 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit IE EP 00978467.9 Abandoned
NIAID E-263-1999-0-IT-14 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit IT EP 00978467.9 Abandoned
NIAID E-263-1999-0-GB-12 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit GB EP 00978467.9 Abandoned
NIAID E-263-1999-0-PCT-02 Methods of Treating Inflammatory Bowel Disease Using Cholera Toxin B Subunit PCT PCT PCT/US00/30837 Expired
NCI E-262-1999-1-PCT-01 HGF-SF Monoclonal Antibody Combinations PCT PCT COMB PCT/US2000/031036 Expired
NINDS E-132-1994-0-US-03 Composition of Immunotoxins and Retinoids and use Thereof US DIV 09/708,837 Abandoned
NCI E-235-2000-0-US-01 Enchanced Efficacy and Safety of Genotoxic Therapy By P38 MAPK Modulation US 60/246,912 Abandoned
NCI E-289-2000-0-US-01 Geldanamycin Derivatives having Selective Affinity For HSP90 Over GRP94 and Method of Using Same US 60/246,258 Abandoned
NIBIB E-143-2000-0-US-01 Sample Delivery System With Laminar Mixing of Microvolume Sensing US 60/245,555 Abandoned
CC E-001-2001-0-US-01 Apheresis Methods and Devices US 60/245,901 Abandoned
NIA E-141-2000-0-US-01 Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof US 60/245,329 Abandoned
NCI E-308-2000-0-US-01 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US 60/245,113 Abandoned
NCI E-120-1999-0-PCT-02 Integrated Low Field MRI/RF EPRI For Co-Registering Imaging Of In Vivo Physiology And Anatomy In Living Objects PCT PCT PCT/US00/30069 Expired
NCI E-120-1999-0-EP-03 Integrated Low Field MRI/RF EPRI For Co-Registering Imaging Of In Vivo Physiology And Anatomy In Living Objects EP National Stage 00980251.3 Abandoned
NIBIB E-025-1997-0-US-07 Mechanical Handling System For Laser Capture Microdissection US National Stage 09/601,559 6720191 Abandoned PDF
NIDDK E-291-2000-0-US-01 Methods and Compositions for Analysis of M3 Muscarinic Acetylcholine Receptors US 60/244,414 Abandoned
NCI E-206-1998-1-PCT-01 Method of In Vitro T-Cell Differentiation Of CD34 Progenitor Cells PCT PCT COMB PCT/US2000/029655 Expired
NHLBI E-166-2000-0-PCT-02 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application PCT PCT PCT/EP00/010886 Abandoned
NHLBI E-166-2000-0-JP-07 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application JP National Stage 20011533845 Expired
NHLBI E-166-2000-0-EP-05 NUCLEIC ACIDS OF THE HUMAN ABC1 GENE AND APPLICATIONS THEREOF EP National Stage 00975997.8 Abandoned
NHLBI E-166-2000-0-CA-04 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application CA National Stage 2388950 Abandoned
NHLBI E-166-2000-0-IL-06 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application IL National Stage 149185 Expired
NHLBI E-166-2000-0-KR-08 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application KR National Stage 10-2002-7005318 Abandoned
NHLBI E-166-2000-0-ZA-10 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application ZA National Stage 200203269 Expired
NHLBI E-166-2000-0-AU-03 Nucleic Acids And Proteins of The Human ABCI Gene And Their Therapeutic And Disgnostic Application AU National Stage 13919/01 Abandoned
NIEHS E-009-1994-2-US-01 Method For Modulating Processes Mediated by Farnesoid Activated Receptors US ORD 09/696,443 6416957 Expired PDF
NIAID E-255-2000-0-US-01 Antibodies and Other Ligands Directed Against KIR2DL4 Receptor For Production of Interferon Gamma US 60/242,419 Abandoned
NCI E-265-1999-0-CA-06 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2 DOMAIN CA National Stage 2387922 Abandoned
NCI E-200-1990-4-US-06 Generation of Immune Responses to Prostate-Specific Antigen (PSA) US CON 09/693,121 7598225 Expired PDF
NCI E-265-1999-0-ES-10 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN ES EP 00992431.7 Abandoned
NCI E-265-1999-0-IT-13 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN IT EP 00992431.7 Abandoned
NCI E-265-1999-0-GB-12 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN GB EP 00992431.7 Abandoned
NCI E-265-1999-0-CH-08 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN CH EP 00992431.7 Abandoned
NCI E-265-1999-0-EP-03 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN EP National Stage 00992431.7 Abandoned
NCI E-265-1999-0-DE-09 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN DE EP 00992431.7 Abandoned
NCI E-265-1999-0-FR-11 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN FR EP 00992431.7 Abandoned